Robert W. Dubois is the chief science officer and executive vice president of the National Pharmaceutical Coun... Read Bio
Paying for treatments or services that don’t offer real value for patients is a pervasive problem in the United States, with as much as $340 billion being spent on low-value or unnecessary care alone. With health care spending projected to reach nearly 20% of GDP in the next decade, eliminating low-value care and the associated costs to our health care system is becoming increasingly critical.
Building upon previous efforts aimed at reducing low-value care, partners of the Going Below The Surface Forum (GBTS) have developed a roadmap to guide health care stakeholders as they consider and implement low-value care interventions. The first in a series of webinars on the topic, this online learning event assisted in defining and understanding low-value care and its importance to various stakeholders.
At the conclusion of the session, participants will be able to:
- Describe the problem of low-value care, both clinically and economically.
- Understand the types of low-value care and what tests and treatments are associated with low-value care.
- Explore if low-value care occurs more often in low cost/high volume services or high cost/low volume services.
AcademyHealth and the National Pharmaceutical Council are proud to co-host this event as partners in Going Below The Surface, the sponsor of this series.